IRIS
CERIELLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.574
AS - Asia 5.416
EU - Europa 3.995
SA - Sud America 1.446
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 5
Totale 30.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.445
SG - Singapore 2.838
UA - Ucraina 1.598
BR - Brasile 1.186
CN - Cina 973
DE - Germania 749
HK - Hong Kong 606
FI - Finlandia 600
VN - Vietnam 419
RU - Federazione Russa 323
IE - Irlanda 251
SE - Svezia 179
KR - Corea 158
TR - Turchia 131
AR - Argentina 125
GB - Regno Unito 89
IT - Italia 77
IN - India 65
CA - Canada 64
BD - Bangladesh 41
ID - Indonesia 37
ZA - Sudafrica 37
EC - Ecuador 36
IQ - Iraq 33
MX - Messico 33
CO - Colombia 29
FR - Francia 22
PK - Pakistan 19
PY - Paraguay 19
EU - Europa 14
MA - Marocco 14
PL - Polonia 14
TN - Tunisia 14
UY - Uruguay 14
VE - Venezuela 14
BE - Belgio 13
ES - Italia 12
IR - Iran 12
PE - Perù 12
AT - Austria 10
KE - Kenya 10
NL - Olanda 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
JP - Giappone 8
PT - Portogallo 8
TW - Taiwan 8
CH - Svizzera 7
DZ - Algeria 7
KZ - Kazakistan 7
UZ - Uzbekistan 7
DO - Repubblica Dominicana 6
JO - Giordania 6
AZ - Azerbaigian 5
LT - Lituania 5
HN - Honduras 4
LB - Libano 4
OM - Oman 4
PA - Panama 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
CZ - Repubblica Ceca 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
NG - Nigeria 3
NI - Nicaragua 3
PH - Filippine 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CR - Costa Rica 2
JM - Giamaica 2
MY - Malesia 2
NP - Nepal 2
PR - Porto Rico 2
RS - Serbia 2
SA - Arabia Saudita 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
Totale 30.539
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.297
Fairfield 2.612
Ann Arbor 2.388
Houston 1.866
Ashburn 1.202
Jacksonville 1.185
Seattle 1.003
Wilmington 927
Cambridge 925
Singapore 763
Hong Kong 605
Dearborn 554
Chandler 528
Beijing 525
Boardman 296
Princeton 265
Dublin 251
Ho Chi Minh City 170
Hefei 158
Seoul 151
San Diego 138
Los Angeles 129
Buffalo 121
Izmir 116
Dallas 102
Munich 100
São Paulo 94
Hanoi 92
Helsinki 64
Ogden 56
Norwalk 49
Redondo Beach 46
New York 43
Ottawa 42
Rio de Janeiro 42
Des Moines 41
San Mateo 35
Belo Horizonte 31
Nanjing 30
The Dalles 28
Grafing 27
Porto Alegre 24
Brasília 22
Kunming 22
Haiphong 21
Udine 21
Nuremberg 20
Johannesburg 18
Nanchang 16
Salvador 16
Campinas 15
Curitiba 15
Quito 15
Denver 14
Guangzhou 14
Mumbai 14
Ribeirão Preto 14
Buenos Aires 13
Jinan 13
Warsaw 13
Baghdad 12
Da Nang 12
Andover 11
Guarulhos 11
Hull 11
Sorocaba 11
São José do Rio Preto 11
Dhaka 10
Guayaquil 10
Hải Dương 10
Leawood 10
Mexico City 10
Santo André 10
Thái Bình 10
Toronto 10
Wuhan 10
Biên Hòa 9
Bogotá 9
Brussels 9
Can Tho 9
Charlotte 9
Chicago 9
Chongqing 9
Frankfurt am Main 9
Montevideo 9
Nairobi 9
Ninh Bình 9
Saint Petersburg 9
Augusta 8
Düsseldorf 8
Fuzhou 8
London 8
Manaus 8
Pelotas 8
Poplar 8
São Gonçalo 8
Tokyo 8
Boston 7
Goiânia 7
Ipatinga 7
Totale 21.787
Salva come PNG Salva come JPEG
Nome #
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 225
Possible role of oxidative stress in the pathogenesis of hypertension. 214
Oxidative stress and diabetes-associated complications. 203
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 185
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. 171
Intra-arterial iloprost for limb ischaemia. 170
The oxygen-release capacity of red blood cells in insulin-dependent diabetics after artificial pancreas. 168
Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. 166
Increased prothrombin fragment 1 + 2 in type I diabetic patients. 164
The metabolic syndrome--a postprandial disease? 164
Acute hyperglycaemia and oxidative stress generation. 159
Does a common mechanism induce diverse complications of diabetes? 157
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. 155
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. 154
Antioxidant therapy in diabetic complications: what is new? 154
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. 154
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation 153
Pregnancy as environmental factor precipitating IDDM. 149
Total radical-trapping antioxidant parameter in NIDDM patients. 149
Antioxidant anti-inflammatory treatment in type 2 diabetes. 149
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report. 149
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. 148
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor 148
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. 147
Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects. 146
D-lysine and non-enzymatic glycation. 146
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. 146
Mean red blood cell volume, narcotic addiction, and glucose tolerance 146
Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy? 146
Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. 145
Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. 145
Aspirin and non-enzymatic glycation. 144
Meal-generated oxidative stress in diabetes. The protective effect of red wine. 143
Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. 143
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. 142
Increased glycosylated proteins in opiate addicts. 142
Guideline for management of postmeal glucose. 142
Congestive heart failure and cognitive impairment in the elderly. 142
Non-enzymatic glycosylation reduces antithrombin III activity 142
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. 141
Macromolecular protein complex: a new way to understand the fibrinogen lowering effect of glycosaminoglycans? 141
Point: postprandial glucose levels are a clinically important treatment target. 141
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. 141
Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. 139
Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. 139
Effects of S 21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients 139
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. 139
Atypical environmental factor in expressing type I (insulin-dependent) diabetes mellitus. 139
Impaired glucose metabolism in heroin and methadone users. 138
Meal-generated oxidative stress in type 2 diabetic patients 138
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial. 138
Glucose metabolism and hyperglycemia. 138
Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. 137
How do we define cure of diabetes? 137
Evidence for a reduced heparin cofactor II biological activity in diabetes. 136
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. 136
Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. 136
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? 136
Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. 136
Postprandial glucose regulation: new data and new implications. 136
Detection of nitrotyrosine in the diabetic plasma: evidence for oxidative stress 135
Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human Umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production 135
Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes. 134
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene. 134
Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. 134
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. 134
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. 133
Fibrinogen plasma levels as a marker of thrombin activation in diabetes. 132
Impaired insulin response to glucose but not to arginine in heroin addicts. 132
Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. 132
The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. 132
Angiotensin-receptor blockers, type 2 diabetes, and renoprotection. 131
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. 131
Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. 131
Consensus algorithm of the American Diabetes Association and the European Association for the Study of Diabetes: some concerns. 131
Opiate addict as diabetic patient? 131
Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia 130
Oxidative stress in diabetes. 130
Pathogenetic loop between diabetes and cell senescence. 130
Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. 129
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans. 129
The combined insulin and sulfonylurea therapy in diabetes of elderly people. 129
Tolrestat in the primary prevention of diabetic neuropathy. 129
Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes. 129
Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP. 128
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. 128
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. 127
Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes. 127
Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. 127
The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. 127
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 127
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. 127
Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. 127
Effects of gliclazide beyond metabolic control. 126
The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. 126
The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. 126
Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress 125
Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. 125
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. 125
Fibrinogen and diabetes mellitus: is it time for intervention trials? 124
Totale 14.195
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.409 0 0 0 0 0 430 289 430 607 125 394 134
2021/20221.932 92 183 69 136 39 105 135 97 18 404 344 310
2022/20231.473 272 52 7 180 122 479 1 90 179 22 38 31
2023/2024324 51 30 9 5 53 47 3 10 83 14 3 16
2024/20254.209 46 292 49 81 50 159 227 192 415 603 640 1.455
2025/20263.898 333 764 710 983 859 249 0 0 0 0 0 0
Totale 30.595